Product NDC: | 11096-001 |
Proprietary Name: | Vermocks |
Non Proprietary Name: | Pyrantel Pamoate |
Active Ingredient(s): | 144 mg/mL & nbsp; Pyrantel Pamoate |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11096-001 |
Labeler Name: | Tarmac Products, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part357B |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120426 |
Package NDC: | 11096-001-01 |
Package Description: | 30 mL in 1 BOTTLE (11096-001-01) |
NDC Code | 11096-001-01 |
Proprietary Name | Vermocks |
Package Description | 30 mL in 1 BOTTLE (11096-001-01) |
Product NDC | 11096-001 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Pyrantel Pamoate |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20120426 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Tarmac Products, Inc. |
Substance Name | PYRANTEL PAMOATE |
Strength Number | 144 |
Strength Unit | mg/mL |
Pharmaceutical Classes |